Zatz M - Search Results

1

Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy.

Zatz M, Rapaport D, Vainzof M, Passos-Bueno MR, Bortolini ER, Pavanello Rde C, Peres CA. Zatz M, et al. J Neurol Sci. 1991 Apr;102(2):190-6. doi: 10.1016/0022-510x(91)90068-i. J Neurol Sci. 1991. PMID: 2072118

2

Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophies.

Zatz M, Shapiro LJ, Campion DS, Oda E, Kaback MM. Zatz M, et al. J Neurol Sci. 1978 May;36(3):349-62. doi: 10.1016/0022-510x(78)90043-6. J Neurol Sci. 1978. PMID: 681967

3

Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.

Zatz M, Frota-Pessoa O, Levy JA, Peres CA. Zatz M, et al. J Genet Hum. 1976 Jun;24(2):153-68. J Genet Hum. 1976. PMID: 965952

4

Use of normal daughters' CPK levels in the estimation of heterozygosity risks in X-linked muscular dystrophies.

Zatz M, Frota-Pessoa O, Peres CA. Zatz M, et al. Hum Hered. 1975;25(5):354-9. doi: 10.1159/000152746. Hum Hered. 1975. PMID: 1222942 No abstract available.

5

Steroids in Duchenne muscular dystrophy.

Zatz M, Pavanello Rde C, Vainzof M, Passos-Bueno MR. Zatz M, et al. Neuromuscul Disord. 1992;2(1):59. doi: 10.1016/0960-8966(92)90028-5. Neuromuscul Disord. 1992. PMID: 1356047 No abstract available.

6

Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk.

Passos-Bueno MR, Bakker E, Kneppers AL, Takata RI, Rapaport D, den Dunnen JT, Zatz M, van Ommen GJ. Passos-Bueno MR, et al. Among authors: zatz m. Am J Hum Genet. 1992 Nov;51(5):1150-5. Am J Hum Genet. 1992. PMID: 1415256 Free PMC article.

7

A deletion including the brain promoter of the Duchenne muscular dystrophy gene is not associated with mental retardation.

Rapaport D, Passos-Bueno MR, Takata RI, Campiotto S, Eggers S, Vainzof M, Makover A, Nudel U, Yaffe D, Zatz M. Rapaport D, et al. Among authors: zatz m. Neuromuscul Disord. 1992;2(2):117-20. doi: 10.1016/0960-8966(92)90043-6. Neuromuscul Disord. 1992. PMID: 1422198

8

Additional dystrophin fragment in Becker muscular dystrophy patients: correlation with the pattern of DNA deletion.

Vainzof M, Passos-Bueno MR, Rapaport D, Pavanello RC, Zatz M, Bulman DE. Vainzof M, et al. Among authors: zatz m. Am J Med Genet. 1992 Oct 1;44(3):382-4. doi: 10.1002/ajmg.1320440323. Am J Med Genet. 1992. PMID: 1488991 No abstract available.

9

A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.

Vainzof M, Passos-Bueno MR, Pavanello RC, Schreiber R, Zatz M. Vainzof M, et al. Among authors: zatz m. J Med Genet. 1992 Jul;29(7):476-9. J Med Genet. 1992. PMID: 1640426 Free PMC article.

10

Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.

Vainzof M, Pavanello RC, Pavanello Filho I, Passos-Bueno MR, Rapaport D, Hsi CT, Zatz M. Vainzof M, et al. Among authors: zatz m. J Neurol Sci. 1990 Sep;98(2-3):221-33. doi: 10.1016/0022-510x(90)90263-m. J Neurol Sci. 1990. PMID: 1700808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

564 results

Search Page

Filters